According to the statistics of China Business Information Network, in 2023, the total market value of Hengrui Pharma ranked first among listed companies in Jiangsu Province, reaching 288.522 billion yuan. Wuxi pharmatech and Guodian NARI ranked second and third respectively, with market values of 2160.07 million yuan and1792.97 million yuan respectively. Yanghe, Huatai Securities, Jiangsu Bank, Nanjing Bank, Zhuo Shengwei, Hengli Hydraulic and Xugong Machinery entered the top ten, ranking 4- 10 in turn. The total market value of the top ten enterprises reached1388184 million yuan, accounting for 2 1.8% of the market value of all listed companies.
The listing formula must meet the following conditions:
1. Its shares are publicly issued with the approval of the securities management department of the State Council. Only limited shares can be raised to become a listed company, and the total share capital of the company is not less than RMB 50 million. The opening time must be more than three years, and it has been profitable continuously in the last three years.
2, through the original state-owned enterprises to set up according to law, or set up after the implementation of the company law. Its main sponsor is a large and medium-sized state-owned enterprise, which can be calculated continuously; The number of shareholders holding shares with a face value of more than RMB 1000 yuan is not less than 1000, and the shares publicly issued to the public account for more than 25% of the total shares of the company; If the company's share capital exceeds 400 million yuan, the proportion of public offering is more than 15%.